|
Market Closed -
Nasdaq
16:00:00 2026-09-04 EDT
|
5-day change | 1st Jan Change | ||
| 33.60 USD | -2.35% |
|
+1.11% | +9.09% |
| 09-03 | Handelsbanken Adds Xvivo and Vimian as Sector Favorites, Drops Danish Duo | FW |
| 09-01 | Deutsche Bank raises price target for Genmab to 2,500 Danish kroner, reiterates buy | FW |
Company Valuation: Genmab A/S
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 172,063 | 192,229 | 140,770 | 94,810 | 124,862 | 129,254 | - | - |
| Change | - | 11.72% | -26.77% | -32.65% | 31.7% | 3.52% | - | - |
| Enterprise Value (EV) 1 | 152,725 | 169,905 | 112,635 | 73,709 | 114,029 | 148,447 | 140,279 | 127,476 |
| Change | - | 11.25% | -33.71% | -34.56% | 54.7% | 30.18% | -5.5% | -9.13% |
| P/E | 57.8x | 35.2x | 32.6x | 12.3x | 20.9x | 27.4x | 19.3x | 12.9x |
| PBR | 7.82x | 7.07x | 4.5x | 2.68x | 3.47x | 3.22x | 2.76x | 2.28x |
| PEG | - | 0.4x | -1.5x | 0.1x | -1x | -1.5x | 0.5x | 0.3x |
| Capitalization / Revenue | 20.3x | 13.2x | 8.54x | 4.4x | 5.31x | 4.47x | 3.83x | 3.17x |
| EV / Revenue | 18x | 11.6x | 6.84x | 3.42x | 4.85x | 5.13x | 4.16x | 3.13x |
| EV / EBITDA | 46.8x | 25.3x | 20.1x | 10.4x | 15.9x | 17.1x | 11.3x | 7.49x |
| EV / EBIT | 50.6x | 26.7x | 21.2x | 10.5x | 17x | 19.2x | 13.9x | 8.96x |
| EV / FCF | 77.3x | 47.3x | 16.1x | 9.72x | 15.7x | 24.8x | 18.3x | 10.7x |
| FCF Yield | 1.29% | 2.12% | 6.23% | 10.3% | 6.36% | 4.03% | 5.47% | 9.34% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | 45.54 | 83.65 | 66.02 | 121.4 | 97.08 | 78.97 | 112.2 | 167.4 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 8,482 | 14,595 | 16,474 | 21,526 | 23,497 | 28,947 | 33,713 | 40,730 |
| EBITDA 1 | 3,266 | 6,719 | 5,616 | 7,116 | 7,175 | 8,699 | 12,412 | 17,030 |
| EBIT 1 | 3,018 | 6,357 | 5,321 | 7,003 | 6,727 | 7,723 | 10,123 | 14,220 |
| Net income 1 | 3,008 | 5,522 | 4,352 | 7,844 | 6,083 | 4,927 | 7,162 | 10,662 |
| Net Debt 1 | -19,338 | -22,324 | -28,135 | -21,101 | -10,833 | 19,193 | 11,025 | -1,777 |
| Reference price 2 | 2,630.00 | 2,941.00 | 2,155.00 | 1,492.50 | 2,027.00 | 2,165.00 | 2,165.00 | 2,165.00 |
| Nbr of stocks (in thousands) | 65,423 | 65,362 | 65,322 | 63,524 | 61,599 | 59,702 | - | - |
| Announcement Date | 2/16/22 | 2/22/23 | 2/14/24 | 2/12/25 | 2/17/26 | - | - | - |
1DKK in Million2DKK
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 20.62x | 7.16x | 14.45x | 1.43% | 69.02B | |
| 37.68x | 9.86x | 30.11x | 0.04% | 66.32B | |
| -77.54x | 14.97x | -72.18x | -.--% | 27.66B | |
| -15.71x | 6.02x | -7.56x | -.--% | 25.84B | |
| 30.64x | 6.56x | 17.04x | -.--% | 26.54B | |
| 27.79x | 5.19x | 17.27x | -.--% | 20.4B | |
| 50.92x | 18.81x | 38.16x | 0.3% | 17.63B | |
| 1308.71x | 37.87x | 826.39x | -.--% | 15.15B | |
| 18.26x | 5.45x | 12.72x | -.--% | 14.65B | |
| Average | 155.71x | 12.43x | 97.38x | 0.2% | 31.47B | |
| Weighted average by Cap. | 83.82x | 10.53x | 52.90x | 0.37% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- GMAB Stock
- GMAB Stock
- Valuation Genmab A/S
Select your edition
All financial news and data tailored to specific country editions
